The Discovery of N-(1-Methy1-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6-((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular DegenerationJOURNAL OF MEDICINAL CHEMISTRYIF6.82018-02-0532PREAI
Long-acting protein drugs for the treatment of ocular diseases治疗眼部疾病的长效蛋白药物NATURE COMMUNICATIONSIF15.72017-03-2344OAAI
Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular DegenerationJOURNAL OF MEDICINAL CHEMISTRYIF6.82015-11-3031OAAI
Reliability of the Mouse Model of Choroidal Neovascularization Induced by Laser PhotocoagulationINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72014-10-1671PREAI